These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 9445202)

  • 1. Mono-L-aspartyl chlorin e6 (NPe6) and hematoporphyrin derivative (HpD) in photodynamic therapy administered to a human cholangiocarcinoma model.
    Wong Kee Song LM; Wang KK; Zinsmeister AR
    Cancer; 1998 Jan; 82(2):421-7. PubMed ID: 9445202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photodynamic therapy using mono-L-aspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: a Phase I clinical study.
    Taber SW; Fingar VH; Coots CT; Wieman TJ
    Clin Cancer Res; 1998 Nov; 4(11):2741-6. PubMed ID: 9829737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and clinical effects of mono-L-aspartyl chlorin e6 (NPe6) photodynamic therapy in adult patients with primary or secondary cancer of the skin and mucosal surfaces.
    Chan AL; Juarez M; Allen R; Volz W; Albertson T
    Photodermatol Photoimmunol Photomed; 2005 Apr; 21(2):72-8. PubMed ID: 15752124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic therapy of intestinal tumors with mono-L-aspartyl chlorin e6 (NPe6): a basic study.
    Kikuchi T; Asakura T; Aihara H; Shiraki M; Takagi S; Kinouchi Y; Aizawa K; Shimosegawa T
    Anticancer Res; 2003; 23(6C):4897-900. PubMed ID: 14981942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic therapy with mono-L-aspartyl chlorin e6 can cause necrosis of squamous cell carcinoma of tongue: experimental study on an animal model of nude mouse.
    Kobayashi W; Liu Q; Nakagawa H; Sakaki H; Teh B; Matsumiya T; Yoshida H; Imaizumi T; Satoh K; Kimura H
    Oral Oncol; 2006 Jan; 42(1):46-50. PubMed ID: 16266818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo studies on the utilization of mono-L-aspartyl chlorin (NPe6) for photodynamic therapy.
    Nelson JS; Roberts WG; Berns MW
    Cancer Res; 1987 Sep; 47(17):4681-5. PubMed ID: 2957047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue distribution and photosensitizing properties of mono-L-aspartyl chlorin e6 in a mouse tumor model.
    Gomer CJ; Ferrario A
    Cancer Res; 1990 Jul; 50(13):3985-90. PubMed ID: 2354446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of photodynamic therapy using a fractionated dosing of mono-L-aspartyl chlorin e6 in a murine tumor.
    Webber J; Leeson B; Fromm D; Kessel D
    J Photochem Photobiol B; 2005 Feb; 78(2):135-40. PubMed ID: 15664500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic properties and photosensitizing responsiveness of mono-L-aspartyl chlorin e6 in a mouse tumor model.
    Ferrario A; Kessel D; Gomer CJ
    Cancer Res; 1992 May; 52(10):2890-3. PubMed ID: 1581904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of photodynamic therapy using mono-L-aspartyl chlorin e6 on vessel constriction, vessel leakage, and tumor response.
    McMahon KS; Wieman TJ; Moore PH; Fingar VH
    Cancer Res; 1994 Oct; 54(20):5374-9. PubMed ID: 7923168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endovascular photodynamic therapy using mono-L-aspartyl-chlorin e6 to inhibit Intimal hyperplasia in balloon-injured rabbit arteries.
    Nagae T; Aizawa K; Uchimura N; Tani D; Abe M; Fujishima K; Wilson SE; Ishimaru S
    Lasers Surg Med; 2001; 28(4):381-8. PubMed ID: 11344521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hematoporphyrin derivative-mediated photodynamic therapy for human nasopharyngeal carcinoma: a comparative study with CNE2 and C666-1 cell lines in vitro].
    Yang XM; Luo RC; Ma HJ; Li LB; Ding XM; Yan X; Lü CW; Zhou XP
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Feb; 27(2):165-7. PubMed ID: 17355926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Photodynamic therapy of hematoporphyrin derivative on human pancreatic carcinoma cell lines].
    Zhao Y; Yang B; Zhang T; Cai L; Zhu Y
    Zhonghua Wai Ke Za Zhi; 2000 Mar; 38(3):204-7. PubMed ID: 11832030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A photodynamic therapy combined with topical 5-aminolevulinic acid and systemic hematoporphyrin derivative is more efficient but less phototoxic for cancer.
    Wang Y; Lin Y; Zhang HG; Zhu J
    J Cancer Res Clin Oncol; 2016 Apr; 142(4):813-21. PubMed ID: 26581214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of 28 porphyrins and their abilities to localize in mammary mouse carcinoma: uroporphyrin I superior to hematoporphyrin derivative.
    El-Far M; Pimstone N
    Prog Clin Biol Res; 1984; 170():661-72. PubMed ID: 6241706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic effect in an experimental bladder tumor treated with intratumor injection of hematoporphyrin derivative.
    Lin CW; Amano T; Rutledge AR; Shulok JR; Prout GR
    Cancer Res; 1988 Nov; 48(21):6115-20. PubMed ID: 2971434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active oxygen intermediates in the degradation of hematoporphyrin derivative in tumor cells subjected to photodynamic therapy.
    Chekulayeva LV; Chekulayev VA; Shevchuk IN
    J Photochem Photobiol B; 2008 Nov; 93(2):94-107. PubMed ID: 18760622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A basic study of photodynamic therapy of experimental hepatoma with ME 2906].
    Nakamura J; Kajiwara H; Nakamura M; Watanabe M; Naganuma K; Tanaka H; Usui S; Sumiyama Y; Saito K; Aizawa K
    Gan To Kagaku Ryoho; 1998 Jul; 25(9):1454-6. PubMed ID: 9703852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of serum on cellular uptake and phototoxicity of mono-L-aspartyl chlorin e6 (NPe6) in vitro.
    Sheyhedin I; Aizawa K; Araake M; Kumasaka H; Okunaka T; Kato H
    Photochem Photobiol; 1998 Jul; 68(1):110-4. PubMed ID: 9679456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of temperature on the efficiency of photodestruction of Ehrlich ascites carcinoma cells sensitized by hematoporphyrin derivative.
    Chekulayeva LV; Shevchuk IN; Chekulayev VA
    Exp Oncol; 2004 Jun; 26(2):125-39. PubMed ID: 15273663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.